Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Tumour Diseases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01874938
What this trial is testing

LY2875358 in Participants With MET Positive, Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
Eli Lilly and Company 15
Not applicableStudy completedNCT03505515
What this trial is testing

Treatment Patterns, Clinical Outcomes, and Healthcare Resource Utilization Associated With Chinese Patients With Advanced Lung Cancer

Who this might be right for
Lung CancerNon-small Cell Lung Cancer NSCLCSmall Cell Lung Cancer SCLC
Bristol-Myers Squibb 6,205
Testing effectiveness (Phase 2)Active Not RecruitingNCT02721732
What this trial is testing

Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic

Who this might be right for
Advanced Malignant Solid NeoplasmCarcinoma of Unknown PrimaryMetastatic Adrenal Gland Pheochromocytoma+16 more
M.D. Anderson Cancer Center 157
Testing effectiveness (Phase 2)Looking for participantsNCT07280832
What this trial is testing

Phase I/II Clinical Study of JMT108 Injection for the Treatment of Advanced Malignant Melanoma and Urinary Tract Tumors

Who this might be right for
Unresectable Locally Advanced or Metastatic MelanomaUnresectable Locally Advanced or Metastatic Urinary Tract Tumors
Shanghai JMT-Bio Inc. 500
Early research (Phase 1)Study completedNCT00722293
What this trial is testing

A Phase I, Open-label, Study of Pazopanib in Combination With Epirubicin or Doxorubicin for Advanced Solid Tumors

Who this might be right for
Neoplasms, Breast
GlaxoSmithKline 111
Large-scale testing (Phase 3)Study completedNCT00905047
What this trial is testing

Xeloda or UFT (Tegafur-uracil) With Folinic Acid in Advanced or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Centre Oscar Lambret 89
Not applicableStudy completedNCT02884947
What this trial is testing

Improving Surgical Outcomes in Patients With Low Grade Gliomas Using Advanced Pre- and Intra-operative MRI

Who this might be right for
Brain Neoplasms
University College, London 31
Testing effectiveness (Phase 2)Looking for participantsNCT05631249
What this trial is testing

Sotorasib in Previously Treated Locally Advanced or Metastatic NSCLC Subjects With Mutated KRAS p.G12C

Who this might be right for
KRAS P.G12CNon Small Cell Lung Cancer
Gustave Roussy, Cancer Campus, Grand Paris 40
Testing effectiveness (Phase 2)Looking for participantsNCT07463248
What this trial is testing

PULSAR Combined With Fecal Microbiota Transplantation for Advanced Hepatocellular Carcinoma Progressing After First-Line Targeted-Immunotherapy

Who this might be right for
Hepatocellular Carcinoma (HCC)
Wang Xin 64
Testing effectiveness (Phase 2)Study completedNCT01969578
What this trial is testing

Androgen Deprivation Therapy in Advanced Salivary Gland Cancer

Who this might be right for
Salivary Gland Cancer
European Organisation for Research and Treatment of Cancer - EORTC 149
Testing effectiveness (Phase 2)Study completedNCT00128843
What this trial is testing

Exemestane Versus Anastrozole as First Line Hormone Therapy in Postmenopausal Metastatic Breast Cancer Patients

Who this might be right for
Breast Cancer
Spanish Breast Cancer Research Group 103
Testing effectiveness (Phase 2)Study completedNCT00035087
What this trial is testing

EPO906 Therapy in Patients With Advanced Colorectal Cancer

Who this might be right for
Colorectal NeoplasmsColonic Neoplasms
Novartis Pharmaceuticals 62
Early research (Phase 1)Study completedNCT00072332
What this trial is testing

Edotecarin and Cisplatin in Treating Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Esophageal CancerGastric CancerUnspecified Adult Solid Tumor, Protocol Specific
Memorial Sloan Kettering Cancer Center
Early research (Phase 1)Not Yet RecruitingNCT05940116
What this trial is testing

A Phase I Clinical Study of HS-20117 in Participants With Advanced Solid Tumors

Who this might be right for
Non-Small Cell Lung CancerSolid Tumor
Hansoh BioMedical R&D Company 322
Large-scale testing (Phase 3)Study completedNCT01906216
What this trial is testing

Sorafenib Chemoembolization Evaluation Controlled Trial

Who this might be right for
Hepatocellular Carcinoma
Air Force Military Medical University, China 199
Testing effectiveness (Phase 2)WithdrawnNCT04430933
What this trial is testing

A Safety and Tolerability Study of NC318 in Combination With Chemotherapy for Subjects With Advanced or Metastatic NSCLC

Who this might be right for
Advanced or Metastatic Solid TumorsNon-Small Cell Lung Cancer
NextCure, Inc.
Post-approval studies (Phase 4)Study completedNCT01199198
What this trial is testing

Tolvaptan in Hyponatremic Cancer Patients

Who this might be right for
Advanced Cancers
M.D. Anderson Cancer Center 52
Testing effectiveness (Phase 2)UnknownNCT05424432
What this trial is testing

Short Course Neoadjuvant Chemo-radiotherapy Plus Toripalimab for Locally Advanced Resectble Squamous Cell Carcinoma of Esophagus

Who this might be right for
Locally Advanced Esophageal Carcinoma
Jiangsu Cancer Institute & Hospital 63
Not applicableStudy completedNCT02793284
What this trial is testing

Advanced Prostate Imaging of Recurrent Cancer After Radiotherapy

Who this might be right for
Prostate Cancer
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 80
Large-scale testing (Phase 3)Study completedNCT01015833
What this trial is testing

Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer

Who this might be right for
Advanced Adult Hepatocellular CarcinomaRecurrent Hepatocellular CarcinomaStage III Hepatocellular Carcinoma AJCC v7+7 more
National Cancer Institute (NCI) 356
Next Page